# The Evaluation and Standardization of Ginseng and Its Components for Blood Pressure Regulation

> **NCT00730951** · PHASE2 · COMPLETED · sponsor: **Unity Health Toronto** · enrollment: 18 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DIETARY_SUPPLEMENT:** Korean Red Ginseng
- **DIETARY_SUPPLEMENT:** Corn Starch

## Key facts

- **NCT ID:** NCT00730951
- **Lead sponsor:** Unity Health Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2008-01
- **Final completion:** 2008-03
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2015-07-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00730951

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00730951, "The Evaluation and Standardization of Ginseng and Its Components for Blood Pressure Regulation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00730951. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*